Professor Manfred Ogris

Professor Manfred Ogris

Department of Pharmaceutical Sciences, Laboratory of MacroMolecular Cancer Therapeutics (MMCT), University of Vienna, Vienna, Austria

Dr. Ogris is Professor for Pharmaceutical Sciences at the University of Vienna and Head of the Laboratory for MacroMolecular Cancer Therapeutics (MMCT). After studying biotechnology at the University of Natural Resources and Life Sciences in Vienna, he carried out his PhD at the Vienna Biocenter on the development and in vivo application of tumor targeted, polycation based gene delivery systems. During his postdoctoral stay at the CRC Institute of Cancer Research, University of Birmingham/UK, he worked on peptide based endosomal escape mechanisms to improve synthetic gene delivery systems. In 2001, Dr. Ogris joined the Faculty of Pharmacy and Chemistry at the Ludwig-Maximilians-University Munich as a work group leader at the Chair of Pharmaceutical Biology and Pharmaceutical Biotechnology. The focus of his ‘Vectorology’ research group was to develop specific and efficient plasmid and siRNA based nucleic acid vectors for treatment of metastatic cancers in combination with chemo- and radiation therapy. In 2009, Dr. Ogris obtained his venia docendi (habilitation) for Pharmaceutical Biology and Pharmaceutical Biotechnology. In 2013, he was appointed as a full professor for Pharmaceutical Biotechnology at the Department for Pharmaceutical Chemistry, Faculty of Life Sciences of the University Vienna, where he founded and heads the MMCT lab. The lab has a strong focus on the development of macromolecular formulations for targeted drug delivery and the development of nucleic acid based therapies.

Updated 28 November 2023